Serveur d'exploration SRAS - Curation (Ncbi)

Index « Keywords » - entrée « Cysteine Proteinase Inhibitors (chemical synthesis) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cysteine Proteases (metabolism) < Cysteine Proteinase Inhibitors (chemical synthesis) < Cysteine Proteinase Inhibitors (chemistry)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
001077 (2005) Yu-San Han [République populaire de Chine] ; Gu-Gang Chang ; Chiun-Gung Juo ; Hong-Jen Lee ; Shiou-Hwei Yeh ; John Tsu-An Hsu ; Xin ChenPapain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition.
001135 (2005) Haitao Yang [République populaire de Chine] ; Weiqing Xie ; Xiaoyu Xue ; Kailin Yang ; Jing Ma ; Wenxue Liang ; Qi Zhao ; Zhe Zhou ; Duanqing Pei ; John Ziebuhr ; Rolf Hilgenfeld ; Kwok Yung Yuen ; Luet Wong ; Guangxia Gao ; Saijuan Chen ; Zhu Chen ; Dawei Ma ; Mark Bartlam ; Zihe RaoDesign of wide-spectrum inhibitors targeting coronavirus main proteases.
002689 (2013) Pillaiyar Thanigaimalai [Japon] ; Sho Konno [Japon] ; Takehito Yamamoto [Japon] ; Yuji Koiwai [Japon] ; Akihiro Taguchi [Japon] ; Kentaro Takayama [Japon] ; Fumika Yakushiji [Japon] ; Kenichi Akaji [Japon] ; Yoshiaki Kiso [Japon] ; Yuko Kawasaki [États-Unis] ; Shen-En Chen [États-Unis] ; Aurash Naser-Tavakolian [États-Unis] ; Arne Schön [États-Unis] ; Ernesto Freire [États-Unis] ; Yoshio Hayashi [Japon]Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
002839 (2014) Yahira M. Báez-Santos [États-Unis] ; Scott J. Barraza ; Michael W. Wilson ; Michael P. Agius ; Anna M. Mielech ; Nicole M. Davis ; Susan C. Baker ; Scott D. Larsen ; Andrew D. MesecarX-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases.
002F97 (2019) Kouji Ohnishi [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenichi Akaji [Japon]Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Cysteine Proteinase Inhibitors (chemical synthesis)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Cysteine Proteinase Inhibitors (chemical synthesis)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cysteine Proteinase Inhibitors (chemical synthesis)
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021